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• Azoxystrobin hyperpolarizes the membranes of rat thymocytes. 
• The hyperpolarization is due to activation of Ca2+-dependent K+ channels. 
• Azoxystrobin depolarizes the membranes in the presence of quinine. 




     Azoxystrobin, a broad-spectrum fungicide, has been increasingly used in the agricultural 
industry. In Japan in 2018, azoxystrobin at five times the normal limit was detected in a shipment 
of Australian barley that had been used in food products. Therefore, the effects of azoxystrobin 
need to be carefully examined to predict potential adverse reactions in humans. In this study, the 
effects of azoxystrobin on the membrane potential and intracellular Ca2+ levels of thymocytes 
have been photochemically examined using flow cytometry. Azoxystrobin hyperpolarized plasma 
membrane potential. This hyperpolarization appeared to be due to the activation of Ca2+-
dependent K+ channels, as both the removal of extracellular Ca2+ and addition of charybdotoxin 
attenuated the observed hyperpolarization. In the presence of quinine, an anti-malarial drug that 
blocks Ca2+-dependent K+ channels, azoxystrobin depolarized the membranes instead. 
Azoxystrobin increased intracellular Ca2+ levels in a concentration-dependent manner through the 
influx of extracellular Ca2+ and intracellular release of Ca2+, as confirmed by reduction in 
azoxystrobin-induced response in the absence of extracellular Ca2+. It appears likely that 
azoxystrobin at micromolar concentrations modifies membrane ion permeability in thymocytes. 
Since changes in membrane potential and intracellular Ca2+ levels occur during typical 
physiological lymphocyte responses, azoxystrobin may disturb lymphocyte function. 
 





     Azoxystrobin is a broad-spectrum fungicide that has seen increased use in the agricultural 
industry every year since it was first introduced in 1998 [1]. This agent blocks electron transfer 
in mitochondrial respiration, resulting in inhibition of ATP production and, ultimately, oxidative 
stress in fungi [2,3]. Azoxystrobin is also toxic to both vertebrates and invertebrates in freshwater 
and marine systems [4]. Due to the potential for contamination, toxicological studies on 
azoxystrobin in non-target organisms (including humans and other mammals) are warranted [5,6]. 
To our knowledge, however, there is no existing data demonstrating toxicity of azoxystrobin in 
humans at environmental levels. In Japan in 2018, azoxystrobin at five times the normal limit was 
detected in a shipment of Australian barley [7]. Barley from the same batch had already been used 
in food products, which the food company voluntarily recalled. This event further shows that the 
effects of azoxystrobin must be carefully examined to predict possible adverse effects in humans 
and wild mammals. 
     In this study, the effect of azoxystrobin on the membrane potential of thymocytes 
(lymphocytes) has been examined through flow cytometry using appropriate fluorescent probes. 
Non-excitable cells are not typically considered a target for azoxystrobin but changes in 
membrane potential also occur in non-excitable cells, including lymphocytes and hepatocytes, 
during normal physiological behavior and may also be affected [8–10]. Furthermore, the principal 
determinants of membrane potential are transmembrane ion gradient and membrane ion 
permeability. These integral factors are maintained by cellular energy metabolism and specific 
membrane-bound ion channels, such as K+ channels. Inhibition of K+ channels in lymphocytes 
results in their malfunction [11–13]. Compounds that affect membrane potentials (such as 
azoxystrobin) may affect some lymphocyte functions, resulting in adverse effects on the immune 
system. Furthermore, the thymus is very active in pre-adolescent and neonatal periods. Due to 
concerns about the adverse effects of azoxystrobin on the health of children, any information 




2. Materials and methods 
2.1. Chemicals 
     Azoxystrobin (standard purity 99.8 %) was purchased from Wako Pure Chemicals (Tokyo, 
Japan). Propidium iodide (PI), bis(1,3-dibutylbarbituric acid)trimethine oxonol (oxonol), and 
Fluo-3-AM were obtained from Invitrogen (Eugene, OR, USA) or Dojindo Molecular 
Technologies, Inc. (Kumamoto, Japan). Ethylenediamine-N,N,N',N'-tetraacetic acid disodium salt 
(EDTA; Dojindo Molecular Technologies, Inc.) was used as a chelator for extracellular divalent 
metal cations such as Ca2+ and Zn2+. N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine 
(TPEN; Dojindo Molecular Technologies, Inc.) was used for chelation of intracellular Zn2+. All 
other reagents were obtained from Wako Pure Chemicals (Tokyo, Japan). 
2.2. Cell preparation 
     Experiments using rats were carried out under approval (T29-52) from the committee of 
Tokushima University (Tokushima, Japan) for animal experiments. The thymus glands of male 
Wistar rats (6–8 week-old) were triturated in chilled Tyrode's solution (2–4 °C) to dissociate 
thymic lymphocytes (thymocytes). The solution containing thymocytes (cell suspension) was 
stored at 36–37 °C for 1 h at least before use in experiments. It is noted that the cell suspension 
contained small amounts of zinc (216.9 ± 14.4 nM) from the cell preparation (composition salts 
in Tyrode's solution and organs) [14].  
     Thymocytes were used in this chemical cytotoxicity experiment because living cells with 
intact membranes are easily dissociated from organs without enzymatic treatment. However, 
during prolonged incubation thymocytes may spontaneously undergo apoptosis. Thus, all 
experiments were conducted within 6–7 h after organ dissection to avoid significant spontaneous 
apoptosis. Since cell shrinkage is one of the parameters detected during early stages of apoptosis 
[15], forward scatter was used to assess cell size. The forward scatter and cell viability in control 
cells were unchanged during the experiment, confirming that apoptosis had not occurred. It is also 
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noted that the information in this study is limited in the aspect of cytotoxic actions of azoxystrobin 
because rat thymocytes are not a right model to address human immune T cell functions. 
     Azoxystrobin (0.3–100 mM in 2 µL dimethyl sulfoxide) was added to the suspension (1998 
µL) to prepare bath concentrations of 0.3–100 µM and the cells were treated with azoxystrobin 
for 1 h. Dimethyl sulfoxide (up to 0.3 %) did not affect cell viability and fluorescent cellular 
parameters measured in this study. A sample (100 µL) from each cell suspension was analyzed by 
flow cytometry. Data acquisition from 2500 or 3000 cells took approximately 10–15 s. Cellular 
parameters monitored using 2500 cells were similar to those estimated using 10000 cells. Thus, 
2500 or 3000 cells were deemed sufficient to study the cellular effects of azoxystrobin. 
2.3. Measurements of cellular parameters with fluorescent probes 
     Fluorescence was analyzed using a flow cytometer and software package (CytoACE-150; 
JASCO, Tokyo, Japan). Azoxystrobin at concentrations used in this study exhibited no 
fluorescence under the experimental conditions described here. PI (5 µM) was added to the 
suspension to allow assessment of cell lethality by measuring the percentage population of cells 
exhibiting PI fluorescence. Measurement of plasma membrane potentials was performed using 1 
µM oxonol. In order to monitor the change in intracellular Ca2+ levels ([Ca2+]i), cells were 
incubated with 1 µM Fluo-3-AM [16] for 50–60 min before the start of measurement. Fluo-3 
fluorescence was monitored in cells in the presence of 10 µM TPEN, as a chelating agent, to avoid 
the contribution of Zn2+ to Fluo-3 fluorescence. Azoxystrobin-induced changes in oxonol and 
Fluo-3 fluorescence were studied only in living cells with intact membranes that did not exhibit 
PI fluorescence. The cells with intact membranes retained Fluo-3 molecules inside the cells. The 
excitation wavelength of all probes (PI, Fluo-3, and oxonol) was 488 nm, and emissions were 
detected at 530 ± 20 nm for oxonol and Fluo-3, and at 600 ± 20 nm for PI. 
2.4. Statistical analysis and presentation 
     The data obtained in these experiments were statistically analyzed using Tukey's 
multivariate method. P-values of < 0.05 indicated significant difference between cell groups. 
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Values are expressed as mean and standard deviation of 4–8 samples. Each experimental series 
was conducted in triplicate unless stated otherwise.  
 
3. Results 
3.1. Changes in oxonol fluorescence induced by azoxystrobin 
     The measured oxonol fluorescence of rat thymocytes was attenuated when the cells were 
treated with 30 µM azoxystrobin for 1 h (Figure 1A). The histogram of oxonol fluorescence was 
observed to shift to a lower intensity, indicating membrane hyperpolarization. Figure 1B 
summarizes the hyperpolarization and cytotoxicity observed in thymocytes exposed to a range of 
azoxystrobin concentrations. The threshold concentration of azoxystrobin for the induction of 
hyperpolarization was approximately 1–3 µM when administered to cells for 1 h (Figure 1B). 
Increase in azoxystrobin concentration (up to 100 µM) further decreased the intensity of oxonol 
fluorescence in a concentration-dependent manner (Figure 1B). When the cells were incubated 
with 100 µM azoxystrobin for 1 h, the percentage of cells exhibiting propidium fluorescence 
(presumably dead cells and/or cells with compromised membranes) increased slightly, but 
significantly (Figure 1B). Peak hyperpolarization by azoxystrobin at non-cytotoxic levels was 
observed at a concentration of 30 µM.   
 (Figure 1 near here) 
3.2. Mechanism of azoxystrobin-induced changes in oxonol fluorescence 
     In order to determine the pathways through which azoxystrobin induces membrane 
hyperpolarization, additional fluorescence experiments were also conducted with a series of 
additives (Figures 2–4). Membrane hyperpolarization usually occurs when the K+ channels open, 
resulting in an increase in membrane K+ permeability. The membranes of rat thymocytes express 
Ca2+-activated K+ channels [17]. To ascertain the role of Ca2+ on azoxystrobin-mediated 
hyperpolarization, the Oxonol fluorescence experiment was repeated under extracellular Ca2+-
free conditions. The effects of azoxystrobin on membrane polarization were tested under 
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extracellular Ca2+-free conditions. As shown in Figure 2, the base level of oxonol fluorescence 
slightly increased under extracellular Ca2+-free conditions, but treatment of cells with 30 µM 
azoxystrobin for 1 h had no significant effect on oxonol fluorescence in the absence of 
extracellular Ca2+. There was a significant decrease in the intensity of oxonol fluorescence in the 
cells treated with azoxystrobin in the presence of extracellular Ca2+ compared to those in the 
extracellular Ca2+-free environment (Figure 2). From these results, it can be assumed that 
extracellular Ca2+ is a key component of azoxystrobin-induced hyperpolarization. 
     To further determine the role of Ca2+-dependent K+ channels in this process, the effect of 
30 µM azoxystrobin was tested in the presence of quinine possessing an inhibitory action on Ca2+-
dependent K+ channels [18]. Treatment of cells with 300 µM quinine alone did not significantly 
change the intensity of oxonol fluorescence. However, treatment with 30–300 µM quinine in the 
presence of 30 µM azoxystrobin significantly increased the intensity of oxonol fluorescence in a 
concentration-dependent manner, indicating depolarization instead of hyperpolarization (Figure 
3). It is surprising that the combination of azoxystrobin and quinine induces strong depolarization 
in lymphocytes.  
     Further experiments were conducted to elucidate the involvement of Ca2+-dependent K+ 
channels, examining the effect of 30 µM azoxystrobin in the presence of 300 nM charybdotoxin 
(CTX; Figure 4), an alternative blocker of Ca2+-dependent K+ channels [19]. The attenuation of 
oxonol fluorescence by 30 µM azoxystrobin in the presence of charybdotoxin was significantly 
reduced compared to that observed in its absence, suggesting that azoxystrobin-induced 
hyperpolarization was partly inhibited by charybdotoxin. Thus, charybdotoxin-sensitive K+ 
channels, presumably Ca2+-dependent K+ channels, may contribute to the azoxystrobin-induced 
hyperpolarization. 
 (Figures 2, 3, and 4 near here) 
3.3. Changes in Fluo-3 fluorescence induced by azoxystrobin 
     Fluo-3 fluorescence is a useful tool for measuring intracellular levels of Ca2+. Fluo-3 
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fluorescence is sensitive not only to Ca2+, but also to Zn2+ [16], which could potentially lead to 
interference when monitoring changes in intracellular Ca2+ ([Ca2+]i) levels. To avoid this 
interference, 10 µM TPEN (a chelator of intracellular Zn2+) was added to the cell suspension in 
this series of Fluo-3 fluorescence experiments (Figure 5). As shown in Figure 5A, treatment of 
cells with 30 µM azoxystrobin shifted the histogram of Fluo-3 fluorescence to a higher intensity 
compared to the control. The threshold concentration of azoxystrobin for the increase of Fluo-3 
fluorescence was less than 3 µM in the presence of TPEN (Figure 5B). Azoxystrobin at 3–30 µM 
produced concentration-dependent augmentation of Fluo-3 fluorescence, indicating 
azoxystrobin-induced increase in [Ca2+]i (Figure 5B). Removal of extracellular Ca2+ greatly 
reduced the augmentation of Fluo-3 fluorescence by 30 µM azoxystrobin, although augmentation 
was still observed (Figure 5C). It is likely that this azoxystrobin-induced augmentation is due to 
extracellular Ca2+ influx and intracellular Ca2+ release. 
 (Figure 5 near here) 
     The combination of azoxystrobin and quinine caused significant depolarization (Figure 3). 
Therefore, a further increase in [Ca2+]i by the combination was reminiscent. As shown in Figure 
6, the simultaneous treatment of cells with 30 µM azoxystrobin and 300 µM quinine for 1 h further 
augmented Fluo-3 fluorescence, indicating further increase in [Ca2+]i. 
(Figure 6 near here) 
 
4. Discussion 
4.1. Mechanism and possible risk 
     Agents that increase intracellular Ca2+ cause membrane hyperpolarization in cells 
possessing Ca2+-activated K+ channels. This also seems to be the case with azoxystrobin. 
Concentrations of azoxystrobin required to elevate [Ca2+]i in thymocytes are similar to those that 
induce hyperpolarization. The attenuation of oxonol fluorescence (indicative of 
hyperpolarization) by azoxystrobin was reduced in the absence of extracellular Ca2+ or in the 
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presence of the Ca2+-dependent K+ channel blocker charybdotoxin. However, the combination of 
azoxystrobin and the alternative blocker quinine caused augmentation of oxonol fluorescence 
(indicative instead of depolarization). Quinine alone did not change oxonol fluorescence, 
indicating that quinine exerts no action on membrane potential. As depolarization can be caused 
by the specific or non-specific increase in membrane permeability of cations, the combination of 
azoxystrobin and quinine may be causing depolarization by increasing membrane permeability. 
If azoxystrobin induces depolarization in the presence of other medical agents, this would result 
in potent cytotoxic action on excitable cells. The combination may further increase the [Ca2+]i in 
excitable cells expressing voltage-dependent Ca2+ channels, resulting in cell death or injury [19–
22]. Quinine is a cytotoxic substance [23-25]. Therefore, it may be not surprising that the 
combination of quinine and azoxystrobin caused significant depolarization. The combination 
further increased the [Ca2+]i, suggesting further increase in membrane permeability by the 
combination. At present, the mechanism of Ca2+ influx by azoxystrobin is not elucidated. It will 
be necessary to identify Ca2+ permeable channels by electrophysiological techniques. 
4.2. Implications 
     The use of azoxystrobin, a broad-spectrum fungicide, increases every year [1]. In Japan, 
2.5 mg/kg of azoxystrobin was detected in a shipment of Australian barley, which had already 
been used in food products [7]. In the present study, the threshold concentration of azoxystrobin 
required to induce changes in cellular parameters was found to be 1–3 µM under in vitro 
experimental conditions. This concentration is approximately equivalent to 0.4–1.2 mg/kg 
(azoxystrobin molecular weight: 403.388 g/mol). Although the pharmacokinetics of azoxystrobin 
in humans and the amount of azoxystrobin present in food products originating from the 
contaminated barley shipment are unknown, it is difficult to imagine that blood levels of 
azoxystrobin would reach 3 µM (1.2 mg/L) as this would require absorption of a significant 
proportion of the 2.5 mg/kg found in the raw material. The pharmacokinetics of oral azoxystrobin 
was studied in rats [26], and it was revealed that more than 85% of the administered azoxystrobin 
 
–11– 
gets excreted unchanged within 48 h in feces (up to 80%) and urine (< 17%). Therefore, the oral 
absorption of azoxystrobin is low, and it also undergoes extensive metabolism. After 
extrapolating these data to human, it can be predicted that the blood concentration of azoxystrobin 
may not get too high after intake of foods containing azoxystrobin. Hence, an adverse effect from 
azoxystrobin in human may be unlikely. However, there is a possibility that azoxystrobin induces 
strong membrane depolarization when in the presence of medical agents. Thus, further 
information on azoxystrobin cytotoxicity and safety, particularly during drug-drug interactions, 
is needed. 
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Figure 1. Azoxystrobin-induced change in Oxonol fluorescence. (A) Azoxystrobin-induced shift 
of Oxonol fluorescence histogram. Histograms were constructed using the fluorescence of 2500 
thymocytes measured 1 h after the start of drug application. Asterisks (*) indicate the histogram 
obtained from cells treated with 30 µM azoxystrobin. (B) Concentration-dependent changes in 
cell lethality (percentage population of cells exhibiting propidium fluorescence) and mean 
intensity of Oxonol fluorescence in cells treated with 0.3–100 µM azoxystrobin. The column and 
bar indicate mean and standard deviation, respectively (n = 4). Asterisks (**) indicate significant 
differences (P < 0.01) between the control group (CONTROL) and groups of cells treated with 
azoxystrobin (AZOXYSTROBIN).  
 
Figure 2. Azoxystrobin-induced changes in Oxonol fluorescence in the absence (upper pair) and 
presence (lower pair) of extracellular Ca2+ (2 mM CaCl2). The column and bar indicate mean and 
standard deviation, respectively (n = 4). Asterisks (**) indicate significant differences (P < 0.01) 
between the control group (CONTROL) and groups of cells treated with 30 µM azoxystrobin 
(AZOXYSTROBIN). Pounds (##) indicate a significant difference (P < 0.01) between the groups 
of cells treated with azoxystrobin in the absence and presence of extracellular Ca2+. 
 
Figure 3. Changes in Oxonol fluorescence induced by 30 µM azoxystrobin in the absence and 
presence of quinine (30–300 µM). The column and bar indicate mean and standard deviation, 
respectively (n = 4). Asterisks (*, **) indicate significant differences (P < 0.05, P < 0.01) between 
the control group (CONTROL) and the test groups. Pounds (##) indicate significant difference (P 
< 0.01) between the groups of cells treated with azoxystrobin in the absence and presence of 




Figure 4. Changes in Oxonol fluorescence induced by 30 µM azoxystrobin in the absence (upper 
pair) and presence (lower pair) of 300 nM charybdotoxin (CTX). The column and bar indicate 
mean and standard deviation, respectively (n = 4). Asterisks (**) indicate significant differences 
(P < 0.01) between the control group (CONTROL) and the group of cells treated with CTX. 
Pounds (##) indicate significant difference (P < 0.01) between the groups of cells treated with 
azoxystrobin in the absence and presence of CTX. 
 
Figure 5. Azoxystrobin-induced changes in Fluo-3 fluorescence. (A) Azoxystrobin-induced shift 
of Fluo-3 fluorescence histogram. Histograms were constructed using the fluorescence of 2500 
thymocytes measured 1 h after the start of drug application. Asterisks (*) indicate the histogram 
obtained from cells treated with 30 µM azoxystrobin. (B) Concentration-dependent changes in 
mean intensity of Fluo-3 fluorescence in cells treated with 0.3–30 µM azoxystrobin. The column 
and bar indicate mean and standard deviation, respectively (n = 4). Asterisks (*, **) indicate 
significant differences (P < 0.05, P < 0.01) between the control group (CONTROL) and groups 
of cells treated with azoxystrobin (AZOXYSTROBIN). (C) Azoxystrobin-induced changes in 
Fluo-3 fluorescence in the absence (upper pair) and presence (lower pair) of extracellular Ca2+ (2 
mM CaCl2). The column and bar indicate mean and standard deviation, respectively (n = 4). 
Asterisks (**) indicate significant differences (P < 0.01) between the control group (CONTROL) 
and groups of cells treated with 30 µM azoxystrobin (AZOXYSTROBIN). Pounds (##) indicate 
significant difference (P < 0.01) between the groups of cells treated with azoxystrobin in the 
absence and presence of extracellular Ca2+. 
 
Figure 6. Changes in Fluo-3 fluorescence induced by 30 µM azoxystrobin in the absence and 
presence of 300 µM quinine. The column and bar indicate mean and standard deviation, 
respectively (n = 3). Asterisks (*, **) indicate significant differences (P < 0.05, P < 0.01) between 
the control group (CONTROL) and the test groups. Pounds (##) indicate significant difference (P 
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< 0.01) between the groups of cells treated with azoxystrobin in the absence and presence of 
quinine.   
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